Organigram Hldgs Inc - OGI STOCK NEWS

Organigram Holdings has appointed Beena Goldenberg as the new Chief Executive Officer, effective September 9, 2021. Goldenberg, a seasoned leader with over 30 years of experience, previously served as CEO of The Supreme Cannabis Company, achieving 50% growth in her first year. Her leadership is expected to enhance Organigram's market position in the evolving cannabis industry. The company focuses on producing high-quality cannabis and expanding its global footprint. Goldenberg's expertise will support product innovation and value generation for shareholders.

Organigram Holdings is launching the Cannabis Innovators Panel, an initiative to gain real-time insights into consumer preferences from 2,500 participants across Canada. This consumer panel aims to enhance product development by obtaining feedback on cannabis products like vapes, edibles, and pre-rolls. According to SVP Megan McCrae, engaging with consumers is vital for creating innovative, consumer-centric products. Organigram operates both domestically and internationally, focusing on high-quality cannabis production.

Organigram Holdings announced its Q3 2021 financial results, reporting a 31% increase in gross revenue to $29.1 million and a 13% rise in net revenue to $20.3 million compared to Q3 2020. The company improved its gross margin to $2.1 million from a loss of $50.2 million last year. Notably, a net loss of $4 million was significantly better than the previous year’s loss of $89.9 million. Q4 2021 is projected to see revenue growth supported by a strong market outlook and new product launches, including high-margin dried flower strains.

Organigram Holdings Inc. (NASDAQ: OGI) announced it will report its earnings for the third quarter Fiscal 2021 on July 13, 2021, before market open. The earnings call is scheduled for 8:00 am Eastern Time on the same day. Investors can register for the call via a provided link and access a replay within 24 hours post-call. Organigram focuses on high-quality indoor cannabis production and has established various brands, while also aiming to expand its international presence.

Organigram Holdings (TSX: OGI, NASDAQ: OGI) announces plans to recruit up to 75 positions across various departments including Operations, Production, and Sales. This expansion accompanies the launch of the Center of Excellence, developed in collaboration with BAT, aimed at innovating cannabis vapour and oral products with an initial focus on CBD. The company emphasizes its commitment to community and quality workforce. Additionally, a career fair will be hosted on June 5, 2021, at its Moncton facility to attract potential job seekers.

Organigram Holdings Inc. (TSX: OGI) has appointed Megan McCrae as the new Senior Vice President of Marketing and Communications, effective immediately. McCrae brings 17 years of experience in consumer packaged goods marketing and sales, with a notable role as CMO at Aphria Inc. where she led brand and product strategy. Her background also includes ten years with Japan Tobacco International and advocacy efforts as Board Chair for the Cannabis Council of Canada. Her expertise aims to enhance Organigram’s marketing efforts across Canada, promoting growth and strategic planning for its cannabis brands.

Organigram Holdings announces the launch of Big Bag o’ Buds, a new lineup of dried flower cannabis products available in a 28g format. These products feature a minimum of 17% THC and include popular cultivars like Ultra Sour, Grapefruit GG4, and Lemon Tree. Tim Emberg, Senior VP of Sales, highlighted the demand for large formats and new strains. Grown in climate-controlled settings, the Big Bag o’ Buds aims to enhance flavor and experience for Canadian consumers. The product is now available at select retailers across Canada.

Organigram Holdings has appointed Borna Zlamalik as Vice President of Innovation, effective immediately. Zlamalik, a seasoned marketer with a strong background in cannabis and consumer goods, will oversee R&D and product development. His previous roles include VP of Marketing at The Valens Company and senior positions at JT International SA. This strategic move is expected to enhance product innovation and commercialization as Organigram aims to expand its cannabis portfolio. Zlamalik will drive innovation efforts nationally from Ontario.

Organigram announced the departure of CEO Greg Engel, effective immediately, while he will continue as a special advisor during the transition. Peter Amirault, the current Board chairman, is appointed as executive chair in the interim until a new CEO is chosen. Engel has been pivotal since 2017, leading the company through challenges and innovations in the cannabis market. The Board expressed gratitude for Engel's contributions. The company is pursuing leadership continuity during the search for a permanent CEO, emphasizing governance and business acumen.